The Filing Desk

Maravai LifeSciences vs PacBio

Maravai LifeSciences MRVI · PacBio PACB · Life Sciences Tools & Services

Maravai LifeSciences reported revenue of $186 million in fiscal 2025, 1.2 times PacBio's $160 million in fiscal 2025. Maravai LifeSciences' revenue fell 28.3% in its latest year, and PacBio's grew 3.9%. Maravai LifeSciences had an operating margin of -115.9%, against -346.1% at PacBio. Free cash flow was −$71 million at Maravai LifeSciences and −$114 million at PacBio.

Side by side

Maravai LifeSciencesPacBio
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$186M$160M
Revenue growth−28.3%3.9%
Revenue growth a year, last 5 years−8.2%15.2%
Gross margin18.3%28.6%
Operating margin−115.9%−346.1%
Net margin−70.4%−341.5%
Free cash flow−$71M−$114M
Free cash flow margin−38.1%−71.2%
Return on capital−32.0%−77.1%
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count4.7%4.0%
Last close$7.54$1.96
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score2 of 93 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Maravai LifeSciencesPacBio
Operating margin
Percent of revenue
Maravai LifeSciencesPacBio
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Maravai LifeSciencesPacBio

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Maravai LifeSciences and PacBio pages.